Donnalee Kathleen Papenfuss Form 3 FASTENAL / Donnalee Kathleen Papenfuss ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Papenfuss Donnalee Kathleen

(Last) (First) (Middle)

26753 COUNTY ROAD 3

(Street)

WINONA MN 55987

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2024

3. Issuer Name and Ticker or Trading Symbol
FASTENAL CO [ FAST ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP-Strategy and Communication

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	157	I	Held in 401(K) Plan

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(1)	12/31/2026	Common Stock	796	23.5	D
Employee Stock Option (Right to Buy)	(1)	12/31/2027	Common Stock	2,364	27.5	D
Employee Stock Option (Right to Buy)	(2)	12/31/2028	Common Stock	3,462	26	D
Employee Stock Option (Right to Buy)	(2)	12/31/2029	Common Stock	3,947	38	D
Employee Stock Option (Right to Buy)	(2)	12/31/2030	Common Stock	3,125	48	D
Employee Stock Option (Right to Buy)	(2)	12/31/2031	Common Stock	2,419	62	D
Employee Stock Option (Right to Buy)	(3)	12/31/2032	Common Stock	3,125	48	D
Employee Stock Option (Right to Buy)	(3)	12/31/2033	Common Stock	2,343	64	D

Explanation of Responses:

1. The option will fully vest and become exercisable over a period of eight years, with 25% of the option vesting and becoming exercisable two years after the relevant vesting period, and the remainder vesting and becoming exercisable proportionately (12.5%) each year thereafter.

2. The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.

3. The option will fully vest and become exercisable over a period of five years, with 20% vesting and becoming exercisable each year following the grant date.

	/s/ John J. Milek , Attorney-in-Fact	11/06/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.